Trump's pledge to apply 100% levy on firms making off-patent medications by 2028 (rising to 200% a year later) unless they move production to US faces formidable commercial and political obstacles
Trump's pledge to apply 100% levy on firms making off-patent medications by 2028 (rising to 200% a year later) unless they move production to US faces formidable commercial and political obstacles
<iframe src="https://hindustansphere.com/embed/cluster/8d4e78fceba80f8dc7dfbf2065c9a785168093c9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Indian pharma firms have little reason to fear Trump's tariff threat"></iframe>
